EBOVAC1

Description

Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen

Accession number

f6ee0ed6-5f11-11eb-917b-acde48001122

Project acronym

EBOVAC1

Project website

http://www.ebovac.org/

Start date

2014-12-01

End date

2021-11-30

Funding

IMI2 - Call 2 (Grant number 115854)

Types

IMI projects

Keywords

IMI projects Infectious diseases Ebola and related diseases Vaccines Ebola+ Clinical trial design Conducting clinical trials